Innovative DNA Approach May Overcome Immunotherapy Resistance in Colorectal Cancer
A breakthrough from the University of Alberta reveals a DNA-based strategy to activate immune responses in colorectal cancers resistant to current immunotherapies, potentially leading to more effective treatments.
A research team from the University of Alberta has made a promising discovery that could enhance the effectiveness of immunotherapy for colorectal cancer, a disease that often resists current treatments. Approximately 80% of colorectal cancers do not respond to existing immunotherapies because they fail to activate a critical immune protein called STING (stimulator of interferon genes). This protein is essential for triggering the body's immune response against tumors. The team identified a specific DNA structure capable of activating STING in resistant cancer cells, opening new avenues for therapy.
Principal investigator Kristi Baker explains that by combining immunotherapies with these specially designed DNA molecules, it may be possible to induce a much stronger immune attack against stubborn cancer cells. Their research, published in Cell Reports, involved experiments on cell cultures, animal models, and human tumor organoids, revealing that highly repetitive DNA regions can activate STING.
First author Shayla Mosley, a Ph.D. candidate, stated that introducing these DNA structures into poorly immunogenic tumors significantly improved STING activation and prompted the formation of cytotoxic T cells capable of killing tumor cells. This approach suggests a potential method to bolster immune responses where current treatments fail.
The study also highlights that radiation and some chemotherapies, which increase the presence of STING-activating DNA, could be combined with this strategy to enhance outcomes. By staying ahead of tumor adaptation, this research aims to create more durable and effective treatments. The team is now further exploring other DNA structures using atomic force microscopy to identify additional candidates.
This research holds significance not only for colorectal cancer patients—who face a high mortality rate—but also offers insights into addressing resistance to immunotherapy across other cancers and diseases involving immune system dysfunction. The work underscores the importance of understanding the molecular mechanisms underlying immune activation and paves the way for innovative combination therapies.
Source: https://medicalxpress.com/news/2025-06-colorectal-cancers-resist-immunotherapy-dna.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Solo adults: How varying languages influence the way we speak to babies
Recent research confirms that adults exaggerate vowel sounds in infant-directed speech across multiple languages, supporting its role in early language development. A comprehensive meta-analysis highlights methodological challenges and the need for cross-cultural studies.
Significant Disparities in Access to Pediatric Kidney Transplants in the UK Highlight Need for Systemic Reforms
A groundbreaking study reveals significant inequalities in access to pediatric kidney transplants across the UK, emphasizing the urgent need for systemic reforms to promote fairness and improve outcomes for vulnerable children.
Updated Beers Criteria Introduces Safer Medication Alternatives for Older Adults
The American Geriatrics Society introduces a new guide with safer medication alternatives to improve prescribing practices for older adults, enhancing patient safety and health outcomes.